Mehani, R., A. Shukla, V. K. Yadav, and R. Sahu. “Evolocumab: Rising Momentum As Novel Antidyslipidemic Drug”. International Journal of Basic & Clinical Pharmacology, vol. 6, no. 7, June 2017, pp. 1538-44, doi:10.18203/2319-2003.ijbcp20172713.